Does OSIMERTINIB Cause Decreased appetite? 706 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 706 reports of Decreased appetite have been filed in association with OSIMERTINIB (TAGRISSO). This represents 2.5% of all adverse event reports for OSIMERTINIB.
706
Reports of Decreased appetite with OSIMERTINIB
2.5%
of all OSIMERTINIB reports
138
Deaths
273
Hospitalizations
How Dangerous Is Decreased appetite From OSIMERTINIB?
Of the 706 reports, 138 (19.5%) resulted in death, 273 (38.7%) required hospitalization, and 28 (4.0%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
Disease progression (607)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which OSIMERTINIB Alternatives Have Lower Decreased appetite Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN